actabiomedicaActa Biomedica ScientificaActa Biomedica Scientifica2541-94202587-9596Scientific Centre for Family Health and Human Reproduction Problems10.29413/ABS.2020-5.6.5actabiomedica-2494Research ArticleАКУШЕРСТВО И ГИНЕКОЛОГИЯOBSTETRICS AND GYNAECOLOGYСовременные представления о клинико-диагностических критериях преждевременной недостаточности яичников (обзор литературы)Modern Concepts of Clinical and Diagnostic Criteria for Premature Ovarian Failure (Literature Review)https://orcid.org/0000-0002-1432-4239СалимоваМ. Д.SalimovaM. D.

аспирант, ФГБНУ «Научный центр проблем здоровья семьи и репродукции человека»

664003, г. Иркутск, ул. Тимирязева, 16, Россия

Timiryazeva str. 16, Irkutsk 664003, Russian Federation

madinochka.salimova@mail.ruНаделяеваЯ. Г.NadelyaevaYa. G.

кандидат медицинских наук, научный сотрудник лаборатории гинекологической эндокринологии

664003, г. Иркутск, ул. Тимирязева, 16, Россия

Cand. Sc. (Med.), Research Officer at the Laboratory of Gynecological Endocrinology

Timiryazeva str. 16, Irkutsk 664003, Russian Federation

ianadoc@mail.ruhttps://orcid.org/0000-0002-8862-5771ДанусевичИ. Н.DanusevichI. N.

доктор медицинских наук, руководитель лаборатории гинекологической эндокринологии

664003, г. Иркутск, ул. Тимирязева, 16, Россия

Timiryazeva str. 16, Irkutsk 664003, Russian Federation

iphr@sbamsr.irk.ruФГБНУ «Научный центр проблем здоровья семьи и репродукции человека»Scientific Centre for Family Health and Human Reproduction Problems202013012021564250Copyright © Салимова М.Д., Наделяева Я.Г., Данусевич И.Н., 20212021Салимова М.Д., Наделяева Я.Г., Данусевич И.Н.Salimova M.D., Nadelyaeva Y.G., Danusevich I.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.actabiomedica.ru/jour/article/view/2494преждевременная недостаточность яичникововариальный резервдиагностика преждевременной недостаточности яичниковбесплодиеаменореяантимюллеров гормонфолликулостимулирующий гормонpremature ovarian failurepremature ovarian insufficiencyovarian reservediagnosis of POIinfertilityamenorrheaanti-Müllerian hormonefollicle-stimulating hormoneReferencesWebber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, et al. ESHRE guideline: Management of women with premature ovarian insufficiency. Hum Reprod 2016; 31(5): 926-937. doi: 10.1093/humrep/dew027Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, et al. ESHRE guideline: Management of women with premature ovarian insufficiency. Hum Reprod 2016; 31(5): 926-937. doi: 10.1093/humrep/dew027Табеева Г.И., Шамилова Н.Н., Жахур Н.А., Позднякова А.А., Марченко Л.А. Преждевременная недостаточность яичников – загадка XXI века. Акушерство и гинекология. 2013; (12): 16-21.Tabeyeva GI, Shamilova NN, Zhakhur NA, Pozdnyakova AA, Marchenko LA. Premature ovarian failure is an enigma of the 21st century. Obstet Gynecol. 2013 (12): 16-21. (In Russ.)Fraison E, Crawford G, Casper G, Harris V, Ledger W. Pregnancy following diagnosis of premature ovarian insufficiency: A systematic review. Reproductive Biomed Online. 2019; 39(3): 467-476. doi: 10.1016/j.rbmo.2019.04.019Fraison E, Crawford G, Casper G, Harris V, Ledger W. Pregnancy following diagnosis of premature ovarian insufficiency: A systematic review. Reprod Biomed Online. 2019; 39(3): 467-476. doi: 10.1016/j.rbmo.2019.04.019Царегородцева М.В., Новикова Я.С., Подолян О.Ф. Преждевременная недостаточность яичников: новые возможности терапии. Климактерий. 2016; (3): 26-31.Tsaregorodtseva MV, Novikova YaS, Podolyan OF. Premature ovarian failure: New therapeutic options. Klimakteriy. 2016; (3): 26-31. (In Russ.)Torrealday S, Kodaman P, Pal L. Premature ovarian insufficiency – an update on recent advances in understanding and management. F1000Res. 2017;6:2069 doi: 10.12688/f1000research.11948.1Torrealday S, Kodaman P, Pal L. Premature ovarian insufficiency – an update on recent advances in understanding and management. F1000Res. 2017;6:2069 doi: 10.12688/f1000research.11948.1Baber RJ, Panay N, Fenton A, IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016; 19(2): 109-150. doi: 10.3109/13697137.2015.1129166Baber RJ, Panay N, Fenton A, IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016; 19(2): 109-150. doi: 10.3109/13697137.2015.1129166Коваленко И.И., Данусевич И.Н., Наделяева Я.Г., Лазарева Л.М., Аталян А.В., Сутурина Л.В. Характеристика пациенток с преждевременной овариальной недостаточности по данным госпитального регистра. Международный журнал прикладных и фундаментальных исследований. 2017; (11-1): 53-56.Kovalenko II, Danusevich IN, Nadelyaeva YaG, Lazareva LM, Atalyan AV, Suturina LV. Characteristics of patients with premature ovarian insufficiency according to the patient registry. Mezhdunarodnyy zhurnal prikladnykh i fundamentalnykh issledovaniy. 2017; (11-1): 53-56. (In Russ.)Cox L, Liu JH. Primary ovarian insufficiency: An update. Int J Womens Health. 2014; (6): 235-243. doi: 10.2147/IJWH.S37636Cox L, Liu JH. Primary ovarian insufficiency: An update. Int J Womens Health. 2014; (6): 235-243. doi: 10.2147/IJWH.S37636Komorowska B. Autoimmune premature ovarian failure. Prz Menopauzalny. 2016; 15(4): 210-214. doi: 10.5114/pm.2016.65666Komorowska B. Autoimmune premature ovarian failure. Prz Menopauzalny. 2016; 15(4): 210-214. doi: 10.5114/pm.2016.65666Kruszyńska A, Słowińska-Srzednicka J. Anti-Müllerian hormone (AMH) as a good predictor of time of menopause. Prz Menopauzalny. 2017; 16(2): 47-50. doi: 10.5114/pm.2017.68591Kruszyńska A, Słowińska-Srzednicka J. Anti-Müllerian hormone (AMH) as a good predictor of time of menopause. Prz Menopauzalny. 2017; 16(2): 47-50. doi: 10.5114/pm.2017.68591Vincent A, Farrell E. Premature menopause. In: Dvornyk V (ed.). Current topics in menopause. Sharjah: Bentham Science; 2013: 414-441. doi: 10.2174/97816080545341130101Vincent A, Farrell E. Premature menopause. In: Dvornyk V (ed.). Current topics in menopause. Sharjah: Bentham Science; 2013: 414-441. doi: 10.2174/97816080545341130101Bilgin EM, Kovanci E. Genetics of premature ovarian failure. Curr Opin Obstet Gynecol. 2015; 27(3): 167-174. doi: 10.1097/GCO.0000000000000177Bilgin EM, Kovanci E. Genetics of premature ovarian failure. Current Opinion in Obstet Gynecol. 2015; 27(3): 167-174. doi: 10.1097/GCO.0000000000000177Pastore LM, Johnson J. The FMR1 gene, infertility, and reproductive decision-making: A review. Front Genet. 2014; (5): 195. doi: 10.3389/fgene.2014.00195Pastore LM, Johnson J. The FMR1 gene, infertility, and reproductive decision-making: A review. Front Genet. 2014; (5): 195. doi: 10.3389/fgene.2014.00195Maclaran K, Nick P. Current concepts in premature ovarian insufficiency. Womens Health (Lond). 2015; 11(2): 169-182. doi: 10.2217/whe.14.82Maclaran K, Nick P. Current concepts in premature ovarian insufficiency. Womens Health (Lond). 2015; 11(2): 169-182. doi: 10.2217/whe.14.82Hudson MM. Reproductive outcomes for survivors of childhood cancer. Obstet Gynecol. 2010; 116(5): 1171-1183. doi: 10.1097/AOG.0b013e3181f87c4bHudson MM. Reproductive outcomes for survivors of childhood cancer. Obstet Gynecol. 2010; 116(5): 1171-1183. doi: 10.1097/AOG.0b013e3181f87c4bNguyen HH, Milat F, Vincent A. Premature ovarian insufficiency in general practice: Meeting the needs of women. Aust Fam Physician.2017; 46(6): 360-366.Nguyen HH, Milat F, Vincent A. Premature ovarian insufficiency in general practice: Meeting the needs of women. Aust Fam Physician.2017; 46(6): 360-366.Петров И.А., Тихоновская О.А., Куприянова И.И., Окороков А.О., Логвинов С.В., Петрова М.С. и др. Механизмы вторичной недостаточности яичников при операциях на органах малого таза (экспериментальное исследование). Акушерство, гинекология и репродукция. 2015; 9(4): 6-17. doi: 10.17749/2070-4968.2015.9.4.006-017Petrov IA, Tikhonovskaja OA, Kuprijanova II, Okorokov AO, Logvinov SV, Petrova MS, et al. Mechanisms of secondary ovarian failure in operations on the pelvic organs (experimental study). Obstetrics, gynecology and reproduction. 2015; 9(4): 6-17. doi: 10.17749/2070-4968.2015.9.4.006-017. (In Russ.)Соснова Е.А. Эмболизация маточных артерий при миоме матки у пациенток репродуктивного возраста и её роль в формировании аутоиммунного оофорита. Архив акушерства и гинекологии им. В.Ф. Снегирева. 2016; 3(2): 81-87. doi: 10.18821/2313-8726-2016-3-2-81-87Sosnova EA. Uterine artery embolization in uterine fibroids patients of reproductive age and its role in shaping of autoimmune oophoritis. V.F. Snegirev Archives of Obstetrics and Gynecology. 2016; 3(2): 81-87. doi: 10.18821/2313-8726-2016-3-2-81-87. (In Russ.)Atabekoglu C, Taskin S, Kahraman K, Gemici A, Taskin EA, Ozmen B, et al. The effect of total abdominal hysterectomy on serum anti-Müllerian hormone levels: A pilot study. Climacteric. 2012; 15(4): 393-397. doi: 10.3109/13697137.2011.642426Atabekoglu C, Taskin S, Kahraman K, Gemici A, Taskin EA, Ozmen B, et al. The effect of total abdominal hysterectomy on serum anti-Müllerian hormone levels: A pilot study. Climacteric. 2012; 15(4): 393-397. doi: 10.3109/13697137.2011.642426Fenton A, Panay N. Does routine gynecological surgery contribute to an early menopause? Climacteric. 2015; 15(1): 1-2. doi: 10.3109/13697137.2012.647623Fenton A, Panay N. Does routine gynecological surgery contribute to an early menopause? Climacteric. 2015; 15(1): 1-2. doi: 10.3109/13697137.2012.647623Muzii L, Di Tucci C, Di Feliciantonio M, Galati G, Di Donato V, Mussela A, et al. Antimüllerian hormone is reduced in the presence of ovarian endometriomas: A systematic review and meta-analysis. Fertil Steril. 2018; 110(5): 932- 940.e1. doi: 10.1016/j.fertnstert.2018.06.025Muzii L, Di Tucci C, Di Feliciantonio M, Galati G, Di Donato V, Mussela A, et al. Antimüllerian hormone is reduced in the presence of ovarian endometriomas: A systematic review and meta-analysis. Fertil Steril. 2018; 110(5): 932-940.e1. doi: 10.1016/j.fertnstert.2018.06.025Amer SA, El Shamy TT, James C, Yosef AH, Mohamed AA. The impact of laparoscopic ovarian drilling on AMH and ovarian reserve: A meta-analysis. Reproduction. 2017; 154(1): R13-R21. doi: 10.1530/REP-17-0063Amer SA, El Shamy TT, James C, Yosef AH, Mohamed AA. The impact of laparoscopic ovarian drilling on AMH and ovarian reserve: A meta-analysis. Reproduction. 2017; 154(1): R13-R21. doi: 10.1530/REP-17-0063Dillon KE, Sammel MD, Prewitt M, Ginsberg JP, Walker D, Mersereau JE, et al. Pretreatment antimüllerian hormone levels determine rate of post therapy ovarian reserve recovery: Acute changes in ovarian reserve during and after chemotherapy. Fertil Steril. 2013; 99(2): 477-483. doi: 10.1016/j.fertnstert.2012.09.039Dillon KE, Sammel MD, Prewitt M, Ginsberg JP, Walker D, Mersereau JE, et al. Pretreatment antimüllerian hormone levels determine rate of post therapy ovarian reserve recovery: Acute changes in ovarian reserve during and after chemotherapy. Fertil Steril. 2013; 99(2): 477-483. doi: 10.1016/j.fertnstert.2012.09.039Fenton AJ. Premature ovarian insufficiency: Pathogenesis and management. J Midlife Health. 2015; 6(4): 147-153. doi: 10.4103/0976-7800.172292Fenton AJ. Premature ovarian insufficiency: Pathogenesis and management. J Midlife Health. 2015; 6(4): 147-153. doi: 10.4103/0976-7800.172292Gersak K, Gersak ZM, Turcin A. Reproductive aging: Perimenopause and psychopathological symptoms. In: Drevensek G (ed.). Sex Hormones in Neurodegenerative Processes and Diseases. IntechOpen; 2018: 95-126. doi: 10.5772/intechopen.74159Gersak K, Gersak ZM, Turcin A. Reproductive aging: Perimenopause and psychopathological symptoms. In: Drevensek G (ed.). Sex Hormones in Neurodegenerative Processes and Diseases. IntechOpen; 2018: 95-126. doi: 10.5772/intechopen.74159Committee on Gynecologic Practice. Committee Opinion No. 698: Hormone Therapy in Primary Ovarian Insufficiency. Obstet Gynecol. 2017; 129(5): e134-e141. doi: 10.1097/AOG.0000000000002044Committee on Gynecologic Practice. Committee Opinion No. 698: Hormone Therapy in Primary Ovarian Insufficiency. Obstet Gynecol. 2017; 129(5): e134-e141. doi: 10.1097/AOG.0000000000002044Наделяева Я.Г., Сутурина Л.В. Синдром поликистоза яичников и менопауза. Доктор.Ру. 2018; 10(154): 47-50. doi: 10.31550/1727-2378-2018-154-10-47-50Nadelyaeva YaG, Suturina LV. Polycystic ovary syndrome and menopause. Doctor.ru. 2018; 10(154): 47-50. doi: 10.31550/1727-2378-2018-154-10-47-50. (In Russ.)Pluchino N, Carmignani A, Cubeddu A, Santoro A, Cela V, Errasti T. Androgen therapy in women: For whom and when. Arch Gynecol Obstet. 2013; 288(4): 731-737. doi: 10.1007/s00404-013-2969-7Pluchino N, Carmignani A, Cubeddu A, Santoro A, Cela V, Errasti T. Androgen therapy in women: For whom and when. Arch Gynecol Obstet. 2013; 288(4): 731-737. doi: 10.1007/s00404-013-2969-7Madaeva I, Semenova N, Berdina O, Kolesnikova L. OSA syndrome and sleep structure in climacteric women in East Siberia: Ethnic aspect. Chest. 2019; 155(4): 307a. doi: 10.1016/j.chest.2019.02.298Madaeva I, Semenova N, Berdina O, Kolesnikova L. OSA syndrome and sleep structure in climacteric women in East Siberia: Ethnic aspect. Chest. 2019; 155(4): 307a. doi: 10.1016/j.chest.2019.02.298Semenova N, Madaeva I, Kolesnikova L. Insomnia in menopausal women: Racial differences. Maturitas. 2019; 124: 165. doi: 10.1016/j.maturitas.2019.04.149Semenova N, Madaeva I, Kolesnikova L. Insomnia in menopausal women: Racial differences. Maturitas. 2019; 124: 165. doi: 10.1016/j.maturitas.2019.04.149Мадаева И.М., Семенова Н.В., Колесникова Л.И. Этнические особенности нарушений сна у женщин климактерического периода. Журнал неврологии и психиатрии им. C.C. Корсакова. 2019; 119(4-2): 44-49. doi: 10.17116/jnevro201911904244Madaeva IM, Semenova NV, Kolesnikova LI. Ethnic features of sleep disorders in climacteric women. S.S. Korsakov Journal of Neurology and Psychiatry. 2019; 119(4): 44-49. doi: 10.17116/jnevro201911904244. (In Russ.)Татарчук Т.Ф., Косей Н.В., Тутченко Т.Н. Преждевременная недостаточность яичников: синдром или диагноз. Клиническая лекция. Репродуктивная эндокринология. 2017; (2): 16-22. doi: 10.18370/2309-4117.2017.34.16-22Tatarchuk TF, Kosei NV, Tutchenko TN. Premature ovarian insufficiency: A syndrome or diagnosis. Clinical lecture. Reproductive endocrinology. 2017; (2): 16-22. doi: 10.18370/2309-4117.2017.34.16-22. (In Russ.)Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOLIntervention questionnaire. Maturitas. 2005; 50(3): 209-221. doi: 10.1016/j.maturitas.2004.06.015Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOLIntervention questionnaire. Maturitas. 2005; 50(3): 209-221. doi: 10.1016/j.maturitas.2004.06.015Cramer DW, Xu H, Harlow BL. Family history as a predictor of early menopause. Fertil Steril. 1995; 64(4): 740-745. doi: 10.1016/s0015-0282(16)57849-2Cramer DW, Xu H, Harlow BL. Family history as a predictor of early menopause. Fertil Steril. 1995; 64(4): 740-745. doi: 10.1016/s0015-0282(16)57849-2Luisi S, Orlandini C, Regini C, Pizzo A, Vellucci F, Petraglia F. Premature ovarian insufficiency: from pathogenesis to clinical management. J Endocrinol Invest. 2015; 38(6): 597-603. doi: 10.1007/s40618-014-0231-1Luisi S, Orlandini C, Regini C, Pizzo A, Vellucci F, Petraglia F. Premature ovarian insufficiency: from pathogenesis to clinical management. J Endocrinol Invest. 2015; 38(6): 597-603. doi: 10.1007/s40618-014-0231-1Abir R, Fisch B, Nahum R, Orvieto R, Nitke S, Rafael ZB. Turner’s syndrome and fertility: current status and possible putative prospects. Hum Reprod Update. 2001; 7(6): 603- 610. doi: 10.1093/humupd/7.6.603Abir R, Fisch B, Nahum R, Orvieto R, Nitke S, Rafael ZB. Turner’s syndrome and fertility: current status and possible putative prospects. Hum Reprod Update. 2001; 7(6): 603-610. doi: 10.1093/humupd/7.6.603Bukman A, Heineman MJ. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update. 2001; 7(6): 581-590. doi: 10.1093/humupd/7.6.581Bukman A, Heineman MJ. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update. 2001; 7(6): 581-590. doi: 10.1093/humupd/7.6.581Panay N, Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynaecol. 2008; 23(1): 129-140. doi: 10.1016/j.bpobgyn.2008.10.008Panay N, Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynaecol. 2008; 23(1): 129-140. doi: 10.1016/j.bpobgyn.2008.10.008Karkanaki A, Vosnakis C, Panidis D. The clinical significance of anti-mullerian hormone evaluation in gynecological endocrinology. Hormones (Athens). 2011; 10(2): 95-103. doi: 10.14310/horm.2002.1299Karkanaki A, Vosnakis C, Panidis D. The clinical significance of anti-mullerian hormone evaluation in gynecological endocrinology. Hormones (Athens). 2011; 10(2): 95-103. doi: 10.14310/horm.2002.1299Кузнецова И.В., Драпкина Ю.С. Роль антимюллерова гормона в женской репродукции. Медицинский алфавит. 2017; 2(10): 9-16.Kuznetsova IV, Drapkina YuS. Role of anti-müllerian hormone in female reproduction. Medical alphabet. 2017; 2(10): 9-16. (In Russ.)Jeppesen JV, Anderson RA, Kelsey TW, Christiansen SL, Kristensen SG, Jayaprakasan K, et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013; 19(8): 519-527. doi: 10.1093/molehr/gat024Jeppesen JV, Anderson RA, Kelsey TW, Christiansen SL, Kristensen SG, Jayaprakasan K, et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013; 19(8): 519-527. doi: 10.1093/molehr/gat024Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update. 2014; 20(3): 370-385. doi: 10.1093/humupd/dmt062Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update. 2014; 20(3): 370-385. doi: 10.1093/humupd/dmt062Fong SL, Visser JA, Welt CK, de Rijke YB, Eijkemans MJC, Broekmans FJ, et al. Serum anti-müllerian hormone levels in healthy females: A nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab. 2012; 97(12): 4650- 4655. doi: 10.1210/jc.2012-1440Fong SL, Visser JA, Welt CK, de Rijke YB, Eijkemans MJC, Broekmans FJ, et al. Serum anti-müllerian hormone levels in healthy females: A nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab. 2012; 97(12): 4650-4655. doi: 10.1210/jc.2012-1440Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WHB. A validated model of serum Anti-Mullerian hormoneKelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WHB. A validated model of serum Anti- Mullerian hormone from conception to menopause. PLoS ONE. 2011; 6(7): e22024. doi: 10.1371/journal.pone.0022024from conception to menopause. PLoS ONE. 2011; 6(7): e22024. doi: 10.1371/journal.pone.0022024Sahmay S, Usta TA, Erel T, Atakul N, Aydogan B. Elevated LH levels draw a stronger distinction than AMH in premature ovarian insufficiency. Climacteric. 2014; 17(2): 197-203. doi: 10.3109/13697137.2013.870149Sahmay S, Usta TA, Erel T, Atakul N, Aydogan B. Elevated LH levels draw a stronger distinction than AMH in premature ovarian insufficiency. Climacteric. 2014; 17(2): 197-203. doi: 10.3109/13697137.2013.870149van Disseldorp J, Lambalk CB, Kwee J, Looman CWN, Eijkemans MJC, Fauser BC, et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod. 2010; 25(1): 221-227. doi: 10.1093/humrep/dep366van Disseldorp J, Lambalk CB, Kwee J, Looman CWN, Eijkemans MJC, Fauser BC, et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod. 2010; 25(1): 221-227. doi: 10.1093/humrep/dep366Randolph Jr JF, Harlow SD, Helmuth ME, Zheng H, McConnell DS. Updated assays for inhibin B and AMH provide evidence for regular episodic secretion of inhibin B but not AMH in the follicular phase of the normal menstrual cycle. Hum Reprod. 2014; 29(3): 592-600. doi: 10.1093/humrep/det447Randolph Jr JF, Harlow SD, Helmuth ME, Zheng H, McConnell DS. Updated assays for inhibin B and AMH provide evidence for regular episodic secretion of inhibin B but not AMH in the follicular phase of the normal menstrual cycle. Hum Reprod. 2014; 29(3): 592-600. doi: 10.1093/humrep/det447Tal R, Seifer DB. Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve. Int J Endocrinol. 2013; 2013: 818912. doi: 10.1155/2013/818912Tal R, Seifer DB. Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve. Int J Endocrinol. 2013; 2013: 818912. doi: 10.1155/2013/818912van Rooij IAJ, Broekmans FJM, Scheffer GJ, Looman CWN, Habbema JDF, de Jong FH, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril. 2005; 83(4): 979-987. doi: 10.1016/j.fertnstert.2004.11.029van Rooij IAJ, Broekmans FJM, Scheffer GJ, Looman CWN, Habbema JDF, de Jong FH, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril. 2005; 83(4): 979-987. doi: 10.1016/j.fertnstert.2004.11.029Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: Preliminary results. Reprod Biomed Online. 2010; 20(2): 280-285. doi: 10.1016/j.rbmo.2009.11.010Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: Preliminary results. Reprod Biomed Online. 2010; 20(2): 280-285. doi: 10.1016/j.rbmo.2009.11.010Rosendahl M, Andersen CY, la Cour Freiesleben N, Juul A, Løssl K, Andersen AN. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril. 2010; 94(1): 156-166. doi: 10.1016/j.fertnstert.2009.02.043Rosendahl M, Andersen CY, la Cour Freiesleben N, Juul A, Løssl K, Andersen AN. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril. 2010; 94(1): 156-166. doi: 10.1016/j.fertnstert.2009.02.043Perloe M, Levy DP, Sills ES. Strategies for ascertaining ovarian reserve among women suspected of subfertility. Int J Fertil Womens Med. 2000; 45(3): 215-224.Perloe M, Levy DP, Sills ES. Strategies for ascertaining ovarian reserve among women suspected of subfertility. Int J Fertil Womens Med. 2000; 45(3): 215-224.Broer SL, Eijkemans MJC, Scheffer GJ, van Rooij IAJ, de Vet A, Themmen APN, et al. Anti-Mullerian hormone predicts menopause: A long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011; 96(8): 2532-2539. doi: 10.1210/jc.2010-2776Broer SL, Eijkemans MJC, Scheffer GJ, van Rooij IAJ, de Vet A, Themmen APN, et al. Anti-Mullerian hormone predicts menopause: A long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011; 96(8): 2532-2539. doi: 10.1210/jc.2010-2776Willis SA, Kuehl TJ, Spiekerman AM, Sulak PJ. Greater inhibition of the pituitary – ovarian axis in oral contraceptive regimens with a shortened hormone-free interval. Contraception. 2006; 74(2): 100-103. doi: 10.1016/j.contraception.2006.02.006Willis SA, Kuehl TJ, Spiekerman AM, Sulak PJ. Greater inhibition of the pituitary – ovarian axis in oral contraceptive regimens with a shortened hormone-free interval. Contraception. 2006; 74(2): 100-103. doi: 10.1016/j.contraception.2006.02.006Nelson SM. Biomarkers of ovarian response: current and future applications. Fertil Steril. 2013; 99(4): 963-969. doi: 10.1016/j.fertnstert.2012.11.051Nelson SM. Biomarkers of ovarian response: current and future applications. Fertil Steril. 2013; 99(4): 963-969. doi: 10.1016/j.fertnstert.2012.11.051Nelson SM. Biomarkers of ovarian response: current and future applications. Fertil Steril. 2013; 99(4): 963-969. doi: 10.1016/j.fertnstert.2012.11.051

The authors declare that there are no conflicts of interest present.